IEEE

A Universal Methodology of Complex Number Computation for Low-Complexity and High-Speed Implementation

Abstract: In complex-valued neural network (CVNN) applications, complex number calculations require high performance rather than high precision. However, most previous studies focused on ...
Frontiers

Navigating hepatotoxicity of antibody-drug conjugates: from mechanistic insights to clinical and postmarketing evidence

Antibody-drug conjugates (ADCs) are rapidly developing targeted cancer therapeutic agents that combine specific monoclonal antibodies with cytotoxic agents. Currently, 17 ADCs are approved for the ...
entrackr

Modulus Housing raises Rs 70 Cr in Series A round

Proptech startup Modulus Housing has raised Rs 70 crore ($7.83 million) in its Series A round led by Kalaari Capital, Hero, and Samarthya. The round also saw participation from SVAS, Sigma, Zetwerk ...
Businessworld

Modulus Housing Secure $7.83 Mn Series A To Scale Biz

IIT-Madras–incubated startup Modulus Housing has raised USD 7.83 million in a Series A funding round led by Kalaari Capital, Hero Enterprise and Samarthya, giving fresh momentum to its push toward ...
IEEE

Physics-Informed Neural Networks for Solving Forward and Inverse Problems in Complex Beam Systems

Abstract: This article proposes a new framework using physics-informed neural networks (PINNs) to simulate complex structural systems that consist of single and double beams based on Euler–Bernoulli ...
C&EN

Structure-Guided Design, Synthesis, and Biological Evaluation of Peripheral Anionic Site Selective and Brain Permeable Novel Oxadiazole-Piperazine Conjugates against Alzheimer ...

Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator. Non-Commercial (NC): Only non-commercial uses of the work are permitted. Article Views ...
C&EN

Dissecting the Efficacy and Immunogenicity of TLR7 Agonist–Antibody Conjugates through the Lens of Fc Effector Function, Conjugation Strategies, and Linker Cleavability

Checkpoint inhibitors have revolutionized cancer treatment by enhancing T-cell responses against tumors, leading to long-term tumor regression. These inhibitors, including anti-PD-1/PD-L1 and ...